Islamabad: The cabinet has deferred a controversial plan of reducing the experience requirement of in-charges production and quality control to recruit candidates with less experience to check quality of medicines.
The cabinet members have expressed serious concerns that it would result in compromising to ensure quality of medicines.
Cabinet Committee for Disposal of Legislative Cases (CCLC) has approved a controversial proposal to reduce the experience requirement of in charge production and in charge quality control to appoint candidates with less experience to check quality of medicines.
During the discussion in a recent meeting chaired by Prime Minister Imran Khan, the attention was invited to agenda regarding proposed amendments in the Drugs (Licensing, Registering and Advertising) Rules 1976 wherein the experience requirements of ‘In-charge Production’ and In-charge Quality Control were being reduced from 10 to 3 years. It was opined that this would compromise quality controls as individuals with less experience will not be able to ensure production of quality medicines.
The ministry explained that the experience requirement was being brought down from 10 to 6 years as it was difficult for the industry to find suitable experienced professionals. It was also informed that the new requirements were similar to those prescribed in many other countries.
The cabinet decided to defer the ratification of the decisions of CCLC relating to proposed amendments in the Drugs (Licensing, Registering and Advertising) Rules 1976 for further discussion in the presence of special assistant to the Prime Minister on National Health Services Regulations and Coordination.
The cabinet also expressed concern on the reports of non-availability of some life-saving drug and directed the ministry of National Health Services, Regulations and Coordination to submit report to cabinet.